Relationships between biomedical companies and guideline makers are often undisclosedBMJ 2016; 353 doi: https://doi.org/10.1136/bmj.i3065 (Published 31 May 2016) Cite this as: BMJ 2016;353:i3065
- Jacqui Wise
Financial relationships between organisations that produce clinical guidelines and biomedical companies are common and often not disclosed in the guidelines, according to research published in PLOS Medicine.1
The Canadian researchers conducted a cross sectional survey and a website review of 290 clinical practice guidelines produced by 95 national or international medical organisations.
All the guidelines were published in 2012 on the National Guideline Clearinghouse …